Navigating cholestasis: identifying inborn errors of bile acid metabolism for precision diagnosis

Inborn errors of bile acid metabolism (IEBAM) cause cholestasis during the neonatal period, and 8 types of IEBAM have been reported to date. IEBAM accounts for approximately 2% of cases of cholestasis of unknown cause. As only 10 patients have been identified in Japan, IEBAM presents diagnostic challenges due to the similarity of clinical symptoms with biliary atresia, thus necessitating precise differentiation to avoid unnecessary invasive procedures. Laboratory tests in IEBAM are characterized by normal γ-glutamyltransferase (GGT) and serum total bile acid (STBA) levels despite the presence of cholestasis; therefore, measuring STBA and GGT is essential to distinguishing biliary atresia from IEBAM. With suspected IEBAM, liquid chromatography–mass spectrometry (LC/MS) analysis of urinary bile acids is needed to optimize diagnostic and therapeutic efficacy and avoid open cholangiography and initiate treatment for primary bile acids such as cholic acid or chenodeoxycholic acid. This prospective report aims to increase awareness of IEBAM by highlighting the characteristics of general blood test and bile acid profiles from LC/MS analyses of blood, urine, and stool samples.

[1]  H. Takei,et al.  Dried blood spot-based newborn screening for bile acid synthesis disorders, Zellweger spectrum disorder, and Niemann-Pick type C1 by detection of bile acid metabolites. , 2023, Molecular genetics and metabolism.

[2]  H. Nittono,et al.  Transient myelodysplasia triggered by parvovirus B19 infection in a male with inborn error of bile acid metabolism , 2023, Pediatric blood & cancer.

[3]  E. Hoshino,et al.  Age at surgery and native liver survival in biliary atresia: a systematic review and meta-analysis , 2023, European Journal of Pediatrics.

[4]  H. Nittono,et al.  Inborn errors of bile acid metabolism in Japan , 2023, Pediatrics international : official journal of the Japan Pediatric Society.

[5]  H. Nittono,et al.  Characterization of long-chain fatty acid-linked bile acids: a major conjugation form of 3β-hydroxy bile acids in feces , 2022, Journal of lipid research.

[6]  H. Kusano,et al.  Urine bile acid profile of a Japanese patient with a bile acid amidation defect. , 2022, Pediatrics international : official journal of the Japan Pediatric Society.

[7]  Yi Lu,et al.  Genetic spectrum and clinical characteristics of 3β-hydroxy-Δ5-C27-steroid oxidoreductase (HSD3B7) deficiency in China , 2021, Orphanet Journal of Rare Diseases.

[8]  H. Nittono,et al.  Changes in conjugated urinary bile acids across age groups , 2020, Steroids.

[9]  H. Nittono,et al.  Bile Acid Synthesis Disorders in Japan: Long-Term Outcome and Chenodeoxycholic Acid Treatment , 2020, Digestive Diseases and Sciences.

[10]  K. Setchell,et al.  Inborn Errors of Bile Acid Metabolism. , 2018, Clinics in liver disease.

[11]  P. Clayton,et al.  Bile acid-CoA ligase deficiency—a new inborn error of bile acid metabolism , 2012, Journal of Inherited Metabolic Disease.

[12]  Jonathan C. Cohen,et al.  Homozygosity mapping identifies a bile acid biosynthetic defect in an adult with cirrhosis of unknown etiology , 2012, Hepatology.

[13]  K. Setchell,et al.  Oral cholic acid for hereditary defects of primary bile acid synthesis: a safe and effective long-term therapy. , 2009, Gastroenterology.

[14]  H. Nittono,et al.  Diagnostic determination system for high‐risk screening for inborn errors of bile acid metabolism based on an analysis of urinary bile acids using gas chromatography–mass spectrometry: Results for 10 years in Japan , 2009, Pediatrics international : official journal of the Japan Pediatric Society.

[15]  K. Setchell,et al.  Defects in bile acid biosynthesis--diagnosis and treatment. , 2006, Journal of pediatric gastroenterology and nutrition.

[16]  L. Pawlikowska,et al.  Atp8b1 deficiency in mice reduces resistance of the canalicular membrane to hydrophobic bile salts and impairs bile salt transport , 2006, Hepatology.

[17]  Y. Sugiyama,et al.  Transport by vesicles of glycine- and taurine-conjugated bile salts and taurolithocholate 3-sulfate: a comparison of human BSEP with rat Bsep. , 2005, Biochimica et biophysica acta.

[18]  Richard J. Thompson,et al.  Progressive familial intrahepatic cholestasis, type 1, is associated with decreased farnesoid X receptor activity. , 2004, Gastroenterology.

[19]  H. Nittono,et al.  3β‐Hydroxy‐Δ5‐C27‐steroid dehydrogenase/isomerase deficiency in a 23‐year‐old woman , 2000, Pediatrics international : official journal of the Japan Pediatric Society.

[20]  A. Kimura,et al.  An infant with 3 β‐hydroxy‐Δ 5 ‐C27‐steroid dehydrogenase/isomerase deficiency presenting with typical neonatal hepatitis syndrome: The first Japanese case , 1998, Acta paediatrica Japonica : Overseas edition.

[21]  Richard J. Thompson,et al.  A gene encoding a liver-specific ABC transporter is mutated in progressive familial intrahepatic cholestasis , 1998, Nature Genetics.

[22]  N. Freimer,et al.  A gene encoding a P-type ATPase mutated in two forms of hereditary cholestasis , 1998, Nature Genetics.

[23]  U. Francke,et al.  Mutations in the bile acid biosynthetic enzyme sterol 27-hydroxylase underlie cerebrotendinous xanthomatosis. , 1991, The Journal of biological chemistry.

[24]  B. F. Kase.  Role of liver peroxisomes in bile acid formation: inborn error of C27-steroid side chain cleavage in peroxisome deficiency (Zellweger syndrome). , 1989, Scandinavian journal of clinical and laboratory investigation.

[25]  F. Suchy,et al.  Delta 4-3-oxosteroid 5 beta-reductase deficiency described in identical twins with neonatal hepatitis. A new inborn error in bile acid synthesis. , 1988, The Journal of clinical investigation.

[26]  P. Clayton,et al.  Familial giant cell hepatitis associated with synthesis of 3 beta, 7 alpha-dihydroxy-and 3 beta,7 alpha, 12 alpha-trihydroxy-5-cholenoic acids. , 1987, The Journal of clinical investigation.

[27]  F. Mashige,et al.  Direct spectrophotometry of total bile acids in serum. , 1981, Clinical chemistry.

[28]  F. Suchy,et al.  Liver Disease in Children: Familial Hepatocellular Cholestasis , 2007 .

[29]  A. Moser,et al.  Liver disease caused by failure to racemize trihydroxycholestanoic acid: gene mutation and effect of bile acid therapy. , 2003, Gastroenterology.

[30]  Edinburgh Research Explorer Identification of a new inborn error in bile acid synthesis: Mutation of the oxysterol 7 alpha-hydroxylase gene causes severe neonatal liver disease , 2022 .